Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, ...

While women tend to be most concerned with cancers such as breast, colorectal, and endometrial, thyroid cancer should be on ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Please provide your email address to receive an email when new articles are posted on . Of 155 young patients diagnosed with differentiated thyroid cancer, 52.3% had excellent response to treatment.

Pulse Biosciences recently reported first patient treatments in a multi-center, first-in-human feasibility study of its FDA-cleared nPulse Vybrance Percutaneous Electrode System using nanosecond ...

Thyroid cancer is poised to become one of the most common cancer diagnoses in living cancer patients. Thyroglobulin (Tg) is thyroid but not tumor specific. Serum Tg levels less or equal to 0.1 ng/ml ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced first ...

The leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. These revised guidelines begin with ...

Young patients often struggle to get early diagnosis of cancer leading to delays and more advanced stages of disease.

GLP-1 drugs like Ozempic and Mounjaro show no increased thyroid cancer risk in human data, despite lawsuits over stomach ...